Episode
Dimitrios Mathios, Washington University in St. Louis - Developing a Blood-Based Test to Detect Brain Cancer Using AI
- Podcast
- The Academic Minute
- Published
- Jun 22, 2026
- Duration seconds
- 150
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-academic-minute-1102038/episodes/dimitrios-mathios-washington-university-in-st-louis-developing-a-blood-based-test-to-detect-brain-cancer-using-ai/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-academic-minute-1102038/dimitrios-mathios-washington-university-in-st-louis-developing-a-blood-based-test-to-detect-brain-cancer-using-ai.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Can artificial intelligence help us detect brain cancer early? Dimitrios Mathios , assistant professor of neurosurgery at Washington University in St. Louis , takes a non-invasive look. Faculty Bio: Dimitrios Mathios, MD, is an assistant professor of neurosurgery and director of the Molecular Neuro-oncology Lab at WashU’s School of Medicine. His research focuses on using cancer immunology, genetics, and epigenetics to develop non-invasive early detection of brain tumors, when they are easily removable or curable with other treatments.Dr. Mathios has published more than 50 peer-reviewed articles in journals like Nature Genetics, Nature Communications, Science Translational Medicine, Cancer Discovery, the Journal of Neurosurgery, the Journal of Neuro-Oncology, and Neurosurgery. His work has resulted in numerous awards, including the Young Investigator Physician Scientist Research Award at John Hopkins University School of Medicine, where he completed his residency, in 2022, and the American Association for Cancer Research-Conquer Cancer Foundation’s ASCO Young Investigator Award for Translational Cancer Research in 2020. Transcript: Diagnosing brain cancer at its earliest stages, like any cancer, is critical. But there are currently no screening methods available to detect brain cancer before a patient becomes symptomatic, or when the symptoms are as commonplace as a headache or slight personality change. As a result, brain cancer often goes undetected when treatment is the easiest, most effective, and least risky.That’s why, in 2019 I began researching a way to develop a noninvasive, blood-based test for early detection of brain cancer.Medical researchers have been looking for and finding ways to detect different kinds of cancer through blood-based tests for more than 1…